Collectively, the results indicate that the higher expression of hnRNPA2B1 is correlated to a more advanced clinical stage and a poorer prognosis of HCC patients, as well as HBV and HCV co-infection. This evidence concerns the gene HNRNPA2B1 and hepatocellular carcinoma.